Cowen Inc’s Edwards Lifesciences EW Stock Holding History

Cowen Inc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,000	Closed	-$882K	–	236
2016 Q1	$882K	Buy	+30,000	New	+$828K	0.03%	151

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Cowen Inc's EW Position: Q3 2015 in Review

Cowen Inc sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 9,018 shares — an estimated $214K sold.

Cowen Inc first reported a position in EW in Q1 2015 and held it in 2 quarters. The position peaked at $214K in Q2 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

Cowen Inc reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
Cowen Inc sold 9,018 Edwards Lifesciences shares in Q3 2015, an estimated $214K.
Cowen Inc first reported a position in Edwards Lifesciences in Q1 2015 and held it in 2 quarters.
Cowen Inc's Edwards Lifesciences position peaked at $214K in Q2 2015.
569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.